Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Andrew L, Pecora"'
Autor:
Andrew L. Pecora, Michele L. Donato, Ling Cai, Melissa Baker, Daniel Kim, Scott D. Rowley, David H. Vesole, Barbara Adler-Brecher, Hongkun Wang, Alan P Skarbnik
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:2047-2055
Most patients eligible for allogeneic hematopoietic stem cell transplantation will require identification of an alternate (unrelated or mismatched related) donor. We explored the transplantation outcomes for a sequential series of 54 patients undergo
Autor:
Sudarsan Kollimuttathuliam, David S. Siegel, Stuart L. Goldberg, Andrew L. Pecora, David H. Vesole, Phyllis McKiernan, Michele L. Donato, Themba Nyirenda, Scott D. Rowley, Andre Goy, Noa Biran
Publikováno v:
Blood. 134:4576-4576
Engraftment syndrome (ES) is a well-defined entity characterized by non-infectious fever and other clinical manifestations including skin rash, pulmonary infiltrates, diarrhea, weight gain and neurological symptoms which happens in the setting of aut
Autor:
David S. Siegel, Phyllis McKiernan, Michele L. Donato, Ning Dong, Andrew L. Pecora, Scott D. Rowley, Noa Biran, David H. Vesole, Alan P Skarbnik
Publikováno v:
Blood. 132:4554-4554
Background: Autologous stem cell transplantation (ASCT) is increasingly offered to older patients with multiple myeloma (MM) based on clinical trials demonstrating improved outcome. Inherently, successful mobilization and collection of peripheral blo
Autor:
Kathleen A. Sobocinski, Steven C. Goldstein, Joseph W. Fay, Chin Yang Li, Armand Keating, Daniel J. Weisdorf, Thomas J. Nevill, Smita Bhatia, Catherine Metayer, Stephanie F. Williams, Carol B. Miller, Rochelle E. Curtis, Douglas Rizzo, Cesar O. Freytes, Lois B. Travis, Andrew L. Pecora, Julie M. Vose, Roger H. Herzig, Mary M. Horowitz
Publikováno v:
Blood. 101:2015-2023
Although numerous reports indicate that patients receiving autotransplants for lymphoma are at increased risk for myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML), the separate contributions of pretransplantation- and transplantation-relat
Autor:
Frank Richter, Anna C. Pavlick, Jack Vitenson, Stuart Levy, John Scheuch, Vincent Lanteri, Gene Rosenberg, Andrew L. Pecora
Publikováno v:
The Prostate Journal. 3:71-75
Objective: Patients with metastatic hormone-refractory prostate cancer have a poor overall survival rate. Newer agents have shown promise in slowing disease progression but are mostly ineffective in improving the overall survival rate, are toxic, and
Autor:
Lori A Leslie, Lori A. Leslie, Tatyana A Feldman, Alan P Skarbnik, David H. Vesole, Scott D. Rowley, Andrew L. Pecora, Andre Goy, Michele L. Donato
Publikováno v:
Blood. 128:5843-5843
Introduction Primary cutaneous T-cell lymphomas (CTCL) are rare subtypes of extranodal non-Hodgkin lymphoma for which no conventional curative therapies are available. Patients (pts) with early-stage, limited disease typically experience an indolent
Autor:
Tatyana Feldman, Harry Agress, Tania Zielonka, Arun K Singavi, Gabriella Gadaletta, Maria Rosario, Andre Goy, Andrew L. Pecora, David Panush, Christina Howlett, Kathryn Waksmundzki, Pritish K. Bhattacharyya, Xiao Yang, Anthony R. Mato, Kar Fai Chow
Publikováno v:
Leukemialymphoma. 54(12)
Subtypes of diffuse large B-cell lymphoma (DLBCL) that have inferior outcomes after front-line therapy with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone) have been identified. While it is agreed that R-CHOP is probably
Autor:
Anthony R, Mato, Jakub, Svoboda, Tatyana, Feldman, Tania, Zielonka, Harry, Agress, David, Panush, Mitchell, Miller, Patrick, Toth, Paul M, Lizotte, Sunita, Nasta, Stuart, Goldberg, Emeline, Chong, Steven, Schuster, Andrew L, Pecora, Andre, Goy
Publikováno v:
Cancer. 118(14)
Although convincing data exist regarding the prognostic utility of positron emission tomographic (PET)-computed tomographic (CT) imaging in Hodgkin lymphoma and diffuse large B-cell lymphoma, its prognostic utility both during treatment and immediate
Autor:
Melissa Baker, Brenda Diaz, Pamela Sutherland, Michele L. Donato, Barbara Adler-Brecher, Daniel Kim, Scott D. Rowley, Michele Boonstra, David H. Vesole, Andrew L. Pecora, Phyllis McKiernan, Alan P Skarbnik
Publikováno v:
Blood. 124:1226-1226
Haploidentical (HAPLO) and unrelated donors (URD) are established cell sources for patients (pts) who lack HLA-matched siblings. Limited data are available comparing transplant (TP) outcomes using cells from HAPLO vs URD donors. We performed a retros
Autor:
Donald Bunjes, Attilio Bondanza, Dietger Niederwieser, Fabio Ciceri, Michele L. Donato, Michael Stadler, Maria Teresa Lupo Stanghellini, Evangelia Yannaki, Raffaella Greco, Lutz Uharek, Jacopo Peccatori, Claudio Bordignon, John F. DiPersio, Arnon Nagler, Wolfgang Bethge, Scialini Colombi, Giacomo Oliveira, Andrew L. Pecora, Lambiase Antonio, Eva Mischak-Weissinger, Chiara Bonini, Eduardo Olovarria, Luca Vago
Publikováno v:
Blood. 124:2535-2535
Background: Haploidentical family donors represent the ideal solution to offer a potential cure for every high-risk leukemia patient undergoing HSCT. Widespread use of haploidentical HSCT has been historically limited by high rates of late non-relaps